If there’s one thing we’ve learned from our clients in the pharmaceutical industry, it’s that change is the only constant.
From new therapies to shifts in strategy to an unprecedented amount of mergers and acquisitions, it seems anymore that the industry is in a perpetual state of flux. Today’s pharmaceutical environment also brings about a new competitive intensity, compressed timelines, and increasing costs. Additionally, gaining access to HCPs has become more challenging than ever before.